Literature DB >> 27125070

ANEMIA IN INFLAMMATORY BOWEL DISEASE MORE THAN AN EXTRAINTESTINAL COMPLICATION.

Roxana Maria Nemeş, Corina Silvia Pop, Dorina Calagiu, Denisa Dobrin, Diana Chetroiu, Petruta Jantea, Paraschiva Postolache.   

Abstract

The most common hematologic complication of inflammatory bowel disease (IBD)--ulcerative colitis and Crohn's Disease is anemia. Anemia in patients with IBD may be a result of iron, vitamin B12 or folate deficiency; anemia of chronic disease and hemolytic anemia are other causes in these patients. Factors contributing to the development of anemia include chronic gastrointestinal blood loss, vitamin B12 malabsorption secondary to terminal ileitis, folate deficiency as a result of sulfasalazine therapy. Approximately 30% of patients with IBD have hemoglobin levels below 12 g/dl. The risk of developing anemia relates to disease activity, given that blood loss and inflammatory anemia are triggered by intestinal inflammation. In the management strategy of IBD patients with anemia it is important to distinguish between the different types of anemia in order to decide an appropriate manner of treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27125070

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  1 in total

1.  Investigation of chronic diseases in patients with inflammatory bowel disease: A hospital-based case-control study.

Authors:  Ali Zabihi; Mehrdad Kashifard; Seyedeh Roghayeh Jafarian Amiri; Mahdi Sepidarkish; Valiollah Padehban; Mojtaba Qanbari Qalehsari
Journal:  Caspian J Intern Med       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.